Autolus Therapeutics plc Annual Net Cash Provided by (Used in) Investing Activities in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Autolus Therapeutics plc quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2016 to 2023.
  • Autolus Therapeutics plc Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was -$533K, a 85.3% increase year-over-year.
  • Autolus Therapeutics plc annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$11M, a 1.34% decline from 2022.
  • Autolus Therapeutics plc annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$10.8M, a 22.4% decline from 2021.
  • Autolus Therapeutics plc annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$8.86M, a 39.7% increase from 2020.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$11M -$145K -1.34% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$10.8M -$1.98M -22.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$8.86M +$5.82M +39.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-21
2020 -$14.7M +$3.99M +21.4% Jan 1, 2020 Dec 31, 2020 20-F 2023-03-07
2019 -$18.7M -$9.14M -95.9% Jan 1, 2019 Dec 31, 2019 20-F 2022-03-10
2018 -$9.53M -$6.66M -231% Oct 1, 2017 Sep 30, 2018 20-F 2020-03-03
2017 -$2.88M -$1.02M -55% Oct 1, 2016 Sep 30, 2017 20-F 2020-03-03
2016 -$1.86M Oct 1, 2015 Sep 30, 2016 20-F 2019-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.